Clinical Trial

Thyroidectomy-specific Enhanced Recovery After Surgery (ERAS) Protocol

Completed
View on ClinicalTrials.gov →
Summary
Thyroidectomy is generally considered a low-to-moderate risk operation; however, postoperative pain, nausea/vomiting, and prolonged hospital stays remain common issues. Enhanced Recovery After Surgery (ERAS) pathways aim to optimize perioperative care and accelerate recovery. This study evaluates the effectiveness and safety of a standardized ERAS pathway in patients undergoing elective thyroidectomy. The prospective ERAS cohort is compared with a historical control group receiving conventional care to assess the impact on the length of hospital stay, postoperative pain, opioid consumption, and complication rates.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-02.
Trial Details
NCT Number NCT07575243
Lead Sponsor Assiut University
Conditions Thyroid Diseases, Goiter, Thyroid Neoplasms
Enrollment 143 participants
Start Date 2024-05-01
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-12